Cannabics Pharmaceuticals enters forbearance on $1.375M defaulted note, forbearance until March 7, 2022

CNBX Pharmaceuticals Inc.

Company defaulted on $1,375,000 Senior Secured Convertible Promissory Note due December 21, 2021.
Investor agrees to forbear from enforcing remedies through March 7, 2022, subject to earlier termination.
Investor waives certain defaults and registration rights during the forbearance period.
Company acknowledges no defenses, offsets, or counterclaims regarding the note and its obligations.
Forbearance terminates automatically on March 7, 2022 or upon a Forbearance Default (5 business days cure).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.